Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Textual)

v3.19.2
Stockholders' Equity (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 15, 2019
Feb. 27, 2019
Feb. 09, 2019
Apr. 25, 2019
May 31, 2018
Feb. 28, 2018
Jul. 31, 2017
Feb. 28, 2017
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2018
May 31, 2019
Jan. 31, 2019
Jan. 02, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Common stock issued for services as per agreement                       $ 307,079          
Common stock, shares issued                           45,267,105      
Common stock issued, value                 $ 468,822   $ 468,822     $ 457,822      
Stock compensation expense                     $ 373,060 340,395          
Exercised and outstanding of warrants                 5,225,533   5,225,533     5,225,533      
Net income (loss)                 $ (962,991) $ (648,571) $ (1,696,554) (8,597)          
Net (loss) attributable to noncontrolling interests                 (144,887) (41,539) (214,702) 12,697          
Net (loss) attributable to Company                 (818,104) $ (607,032) (1,481,852) $ (21,294)          
Intrinsic value of options exercisable                 0   0     $ 0      
Intrinsic value of options outstanding                 $ 0   $ 0     0      
Options expire date, description                     The warrants expire at various times between September 2019 and March 2028.            
Ownership interest                 100.00%   100.00%            
Warrant [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Warrants to purchase of common stock         2,391,305               100,000        
Warrants exercise price         $ 0.28               $ 0.50        
Exercise price                     $ 0.28            
short-term note agreement [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Common stock issued for services as per agreement   $ 100,000                              
Performance Based Stock Options [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock compensation expense               $ 55,439                  
Performance Based Stock Options [Member] | Unvested [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Options fully vested and expiration period             10 years                    
Purchase of common stock             6,000,000                    
Intrinsic value of options exercised               $ 55,439                  
Number of stock options issued               250,000                  
Weighted average exercise price stock option issued             $ 0.28 $ 0.40                  
Annual sales revenue target               $ 5,000,000                  
Stock options, expiration date               Dec. 31, 2027                  
Options fully vested and expiration period             10 years                    
Aggregate fair value             $ 1,688,212                    
Conversion Labs [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Common stock, shares issued       5,000,000           250,000   250,000          
Common stock issued, value       $ 900,000           $ 62,500   $ 62,500          
Stock compensation expense                 $ 191,000 256,000 $ 373,000 340,000          
Exercise price       $ 0.18                          
Net income (loss)                 $ (36,000) $ (23,000) $ 97,000 $ (481,000)          
Ownership interest       100.00%                     51.00%    
Conversion labs PR interest, description       The Company entered into an membership purchase agreement with entities owned by the Company’s Chief Executive officer and Chief Technology Officer, Conversion Labs PR, whereby the Company acquired the remaining 21.8% interest of Conversion Labs PR from the Company’s Chief Executive officer and Chief Technology Officer. As such, the Company now wholly-owns 100% of Conversion labs PR.                          
Conversion Labs [Member] | Unvested [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Conversion labs PR interest, description       Concurrent with the Company’s purchase of the remaining 21.8% interest of Conversion Labs PR, these options were cancelled.                          
CVLB PR [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Option vesting, description             The Company granted performance-based options to purchase 3,750,000 shares of common stock with an exercise prices of $0.25 and $0.35 per share. The options expire in 10 years and become exercisable upon the company achieving pre-tax earnings benchmarks between $4,000,000 and $7,000,000. The aggregate fair value of these performance-based options is $1,152,849. As of February 2018, 2,000,000 of these options had been cancelled.                    
President [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Number of shares cancelled           2,000,000                      
Chief Financial Officer [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Common stock, shares issued     500,000                            
Shares of common stock, value $ 73,000                                
Shares of common stock, shares 500,000                                
Exercise price $ 0.23                                
Option exercised, shares     500,000                            
Option vesting, description     The Company agreed to amend certain options granted to Mr. Kalkstein by decreasing the exercise price of 500,000 options for the Company?s common stock previously granted to Mr. Kalkstein from $0.40 per share to $0.28 per share; accelerate the vesting of 150,000 Options with such options to vest on March 31, 2019; and cancel 200,000 unvested options, the vesting of which was not accelerated.                            
Consultant [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Stock Issued During Period Rescinded Shares         500,000                        
Reissued common stock         250,000                        
Consultant [Member] | Unvested [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Conversion labs PR interest, description       Concurrent with the Company’s purchase of the remaining 21.8% interest of Conversion Labs PR, these options were cancelled.                          
JLS Ventures [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Issuance of company stock, shares         1,000,000                        
Common stock issued for services as per agreement, shares         1,000,000                        
Common stock issued for services as per agreement         $ 230,000                        
Common stock, shares issued                               1,000,000 1,000,000
Common stock issued, value                               $ 230,000  
Consulting Services [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Common stock, shares issued         200,000         500,000   500,000          
Common stock issued, value         $ 56,000         $ 120,000   $ 120,000          
Issuance Of Common Stock [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Sale of stock, price per share $ 0.23                                
Common stock issued, value $ 500,000                                
Issuance Of Common Stock [Member] | short-term note agreement [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Common stock issued for services as per agreement, shares   100,000                              
Common stock issued for services as per agreement   $ 16,000                              
Convertible Note Holders [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                  
Shares of common stock, value                           $ 344,641      
Shares of common stock, shares                           1,498,442      
Exercise price                           $ 0.23